Megakaryocyte lineage development is controlled by modulation of protein acetylation.
Treatment with lysine deacetylase inhibitors (KDACi) for haematological malignancies, is accompanied by haematological side effects including thrombocytopenia, suggesting that modulation of protein acetylation affects normal myeloid development, and specifically megakaryocyte development. In the cur...
Main Authors: | Marije Bartels, Anita Govers, Roel Polak, Stephin Vervoort, Ruben van Boxtel, Cornelieke Pals, Marc Bierings, Wouter van Solinge, Toine Egberts, Edward Nieuwenhuis, Michal Mokry, Paul James Coffer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5919413?pdf=render |
Similar Items
-
SOX4 mediates TGF-β-induced expression of mesenchymal markers during mammary cell epithelial to mesenchymal transition.
by: Stephin J Vervoort, et al.
Published: (2013-01-01) -
Matrix Mechanosensation in the Erythroid and Megakaryocytic Lineages
by: Christina M. Ward, et al.
Published: (2020-04-01) -
MicroRNAs in erythroid and megakaryocytic differentiation and megakaryocyte-erythroid progenitor lineage commitment
by: Zhang, L., et al.
Published: (2014) -
Transcriptomic and Epigenomic Profiling of Histone Deacetylase Inhibitor Treatment Reveals Distinct Gene Regulation Profiles Leading to Impaired Neutrophil Development
by: Anita M.A.P. Govers, et al.
Published: (2019-08-01) -
C/EBPɑ is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transition
by: Ana Rita Lourenço, et al.
Published: (2020-02-01)